The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is sponsoring a study here at Northwestern Medicine to optimize medication management for women who take antidepressants during pregnancy.
Why is this research important?
Depression in pregnancy affects one in seven mothers and causes suffering to mothers and risks to the healthy development of their children. How to treat women optimally during pregnancy will be determined by this research.
Many women take antidepressants during pregnancy to help manage their mood symptoms, but additional information is needed to help providers optimize treatment.
Your participation in this study may lead to knowledge that can help improve antidepressant treatment for other mothers in the future. Our expert team will also communicate with your current prescriber to provide enhanced monitoring during this important time.
You may be eligible to participate if you:
- Are 18 years of age or older
- Are currently at or less than 18 weeks pregnant
- Speak English
- Have received a diagnosis of depression
- Take sertraline (Zoloft), fluoxetine (Prozac), citalopram (Celexa), or escitalopram (Lexapro) and plan to continue it during pregnancy and postpartum
You are not eligible to participate if you:
- Are pregnant with twins
- Are currently taking other medications for your depression in addition to those listed above
- Take other prescribed medication daily (aspirin is okay)
- Blood draws for drug levels every 4 weeks
- Monthly assessments of your mood and medication side effects
- $30 for each completed study visit
- Free on-site parking
If you are interested in participating or would like to hear more information, please contact our research team at email@example.com or 1-855-99-ASHER.